Dissemination
• Scientific Publications
• Scientific Presentations
Scientific Publications
RhoA and Rho kinase mediate cyclosporine A and sirolimus-induced barrier tightening in renal proximal tubular cells.
Martin-Martin N, Dan Q, Amoozadeh Y, Waheed F, McMorrow T, Ryan MP, Szászi K.
Int J Biochem Cell Biol. 2012 44(1):178-88
http://www.ncbi.nlm.nih.gov/pubmed/22062948
Cyclosporine A-induced oxidative stress in human renal mesangial cells: a role for ERK 1/2 MAPK signalling.
O'Connell S, Tuite N, Slattery C, Ryan MP, McMorrow T.
Toxicol Sci. 2011 Dec 6
http://www.ncbi.nlm.nih.gov/pubmed/22147139
In-silico human genomics with GeneCards.
Stelzer G, Dalah I, Stein TI, Satanower Y, Rosen N, Nativ N, Oz-Levi D, Olender T, Belinky F, Bahir I, Krug H, Perco P, Mayer B, Kolker E, Safran M, Lancet D.
Hum Genomics. 2011 5(6):709-17
http://www.ncbi.nlm.nih.gov/pubmed/22155609
TGF-β1 mediates sirolimus and cyclosporine A-induced alteration of barrier function in renal epithelial cells via a noncanonical ERK1/2 signaling pathway.
Martin-Martin N, Slattery C, McMorrow T, Ryan MP.
Am J Physiol Renal Physiol. 2011 301(6):F1281-92
http://www.ncbi.nlm.nih.gov/pubmed/21880834
Relationship between Magnesium and Clinical Biomarkers on Inhibition of Vascular Calcification.
Salem S, Bruck H, Bahlmann FH, Peter M, Passlick-Deetjen J, Kretschmer A, Steppan S, Volsek M, Kribben A, Nierhaus M, Jankowski V, Zidek W, Jankowski J.
Am J Nephrol. 2011 35(1):31-39
http://www.ncbi.nlm.nih.gov/pubmed/22179063
Scientific Presentations
American Society of Nephrology (ASN) Renal Week 2011
November 9-13, 2011, Philadelphia, PA, USA
Presentation titles of contributions at the ASN are listed below:
Merel Hellemons
- Inital Angiotensin Receptor Blockade induced Decrease in Albuminuria is Associated with Long Term Renal Outcome in Type 2 Diabetic Patients with Microalbuminuria; a Post-hoc Analysis of the IRMA-2 trial. [Poster TH-PO24]
- Growth-differentiation Factor 15 and High-sensitivity Troponin-T Predict Progression of Albuminuria in Diabetes and Hypertension; results of a nested case-control study. [Poster TH-PO50]
Carmine Zoccali
- Phosphate, CKD Progression and ACE-Inhibition: A post-hoc Analysis of the REIN Trial.
- Visit to visit blood pressure variability and cardiovascular risk in CKD patients.
Carlamaria Zoja
- Effects of MCP-1 inhibition by bindarit therapy in a rat model of polycystic kidney disease (PKD). [Poster SA-PO2219]
Peter Rossing
- Aliskiren Added to Losartan Has Beneficial Effects across Different Levels of Albuminuria in Hypertensive Patients with Type 2 Diabetes and Nephropathy: The AVOID Study [TH-PO520]
- FGF23 and Asymptomatic Coronary Artery Disease in Type 2 Diabetic Patients with Elevated Urinary Albumin Excretion Rate [TH-PO512]
- YKL-40 Levels Are Associated with Coronary Calcium Score in Type 2 Diabetic Patients with Albuminuria but without Known Cardiovascular Disease [TH-PO510]
- Spironolactone Diminishes Urinary Albumin Excretion in Type 1 Diabetic Patients with Microalbuminuria: A Randomized Placebo-Controlled Crossover Study [TH-PO548]
- Is Microalbuminuria Still the Primary Marker of Early Diabetic Nephropathy?
Peter Rossing, Maria Lajer
- Blood Pressure Measurement in Diabetes – New Techniques and Validity of Current Modalities in Hypertension Diagnostics [PUB391]
- Evaluation of Bone Mineral Density in Long-Standing Type 1 Diabetic Patients with or without Diabetic Nephropathy [SA-PO2280]
Peter Rossing, Merel Hellemons, Stephan Bakker, Dick de Zeeuw, Hiddo Heerspink
- Albuminuria Response to Angiotensin Receptor Blockade Is a Determinant of Renal Protection in Patients with Type 2 Diabetes and Microalbuminuria in the IRMA-2 Trial [TH-PO245]
Peter Rossing, Stephan Bakker
- Urinary Sulphate Excretion Is a Predictor for Progression of Diabetic Nephropathy [TH-PO498]
Julia Wilflingseder
- Renal allograft rejection and delayed graft function regulated by miRNAs
Markus Pirklbauer
- Oncostatin M is a Novel Inhibitor fo TGF-beta1-induced CTGF Expression in Human Proximal Tubular Cells.
